taxonomy (5)
protein (77)
source (16)
structure (12)
composition (1)
disease (6)
reference (26)
site (109)
peptide (93)
- Homo sapiens (Human)
- Mus musculus (House mouse)
- Gallus gallus (Chicken)
- Torpedo californica (Pacific electric ray)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- ADAM DEC1 / Homo sapiens O15204
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-2-HS-glycoprotein / Homo sapiens P02765
- Alpha-2-macroglobulin / Homo sapiens P01023
- Alpha-fetoprotein / Homo sapiens P02771
- Alpha-mannosidase 2 / Homo sapiens Q16706
- Apolipoprotein b-100 / Homo sapiens P04114
- Apolipoprotein d / Homo sapiens P05090
- Apolipoprotein M / Homo sapiens O95445
- Asporin / Homo sapiens Q9BXN1
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Biglycan / Homo sapiens P21810
- Cadherin-2 / Homo sapiens P19022
- Ceruloplasmin / Homo sapiens P00450
- Collagen alpha-1(XII) chain / Homo sapiens Q99715
- Complement factor h / Homo sapiens P08603
- Corticosteroid-binding globulin / Homo sapiens P08185
- Decorin / Homo sapiens P07585
- Desmoglein-2 / Homo sapiens Q14126
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 / Homo sapiens P04844
- Epididymis-specific alpha-mannosidase / Homo sapiens Q9Y2E5
- Fibrillin-1 / Homo sapiens P35555
- Fibrinogen beta chain / Homo sapiens P02675
- Fibrinogen gamma chain / Homo sapiens P02679
- Fibronectin / Homo sapiens P02751
- Glycodelin-a / Homo sapiens P09466
- Glycophorin-A / Homo sapiens P02724
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Hepatocyte growth factor receptor / Homo sapiens P08581
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin alpha (secretory) / Homo sapiens P01876 P01877
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant gamma 1 / Homo sapiens P01857
- Immunoglobulin heavy constant gamma 2 / Homo sapiens P01859
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Integrin alpha-5 / Homo sapiens P08648
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Lactotransferrin / Homo sapiens P02788
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Matrix metalloproteinase-9 / Homo sapiens P14780
- Myelin protein P0 / Homo sapiens P25189
- Periostin / Homo sapiens Q15063
- Plexin-B2 / Homo sapiens O15031
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prolactin-inducible protein / Homo sapiens P12273
- Prominin-1 / Homo sapiens O43490
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen (psa-1) / Homo sapiens P07288
- Prothrombin / Homo sapiens P00734
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Reelin / Homo sapiens P78509
- Reticulocalbin-3 / Homo sapiens Q96D15
- RNA polymerase II elongation factor ELL2 / Homo sapiens O00472
- Serotransferrin / Homo sapiens P02787
- Serum paraoxonase/arylesterase 1 / Homo sapiens P27169
- Tenascin / Homo sapiens P24821
- Tenascin-N / Homo sapiens Q9UQP3
- Thrombospondin-1 / Homo sapiens P07996
- Transmembrane glycoprotein NMB / Homo sapiens Q14956
- Uncharacterized protein from Serum / Homo sapiens
- Uncharacterized protein KIAA0232 / Homo sapiens Q92628
- Unspecified mucin / Homo sapiens
- Von willebrand factor / Homo sapiens P04275
- CD166 antigen / Mus musculus Q61490
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus Q9Z218
- Glutamate receptor 3 / Mus musculus Q9Z2W9
- Laminin subunit alpha-2 / Mus musculus Q60675
- Laminin subunit gamma-1 / Mus musculus P02468
- Neural cell adhesion molecule L1 / Mus musculus P11627
- Thy-1 membrane glycoprotein / Mus musculus P01831
- Riboflavin-binding protein / Gallus gallus P02752
- Acetylcholine receptor protein / Torpedo californica P02718 P02710 P02712 P02714
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Amniotic Fluid (UBERON_0000173)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Electric Organ (UBERON_0006869)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- Erythrocyte (CL_0000232) Plasma Membrane (GO_0005886)
- Neutrophil (CL_0000775)
- Low-Density Lipoprotein Particle (GO_0034362)
- Yolk (GO_0060417)
Source
- N-Linked / Complex / Structure 231
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 2x HexNAc + NeuAc "
- O-Linked / Core 2 / Gal(b1-3)GlcNAc(b1-3)[Gal(b1-4)GlcNAc(b1-6)]Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / Gal(b1-?)GlcNAc(?1-?)[Gal(b1-?)GlcNAc(?1-?)]Gal(b1-?)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
- O-Linked / Core 2 / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-?)Gal(b1-4)GlcNAc(b1-?)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
- O-Linked / Undefined core / Gal(?1-?)GlcNAc(?1-?)Gal(?1-?)GlcNAc(?1-?)Gal(?1-?)GlcNAc(?1-?)[NeuAc(?2-?)Gal(?1-?)]GalNAc
Reported structure
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
Composition
- Cancer, breast (DOID:1612)
- COVID-19 (DOID:0080600)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Esophageal cancer (DOID:5041)
- Hypercholesterolemia, Familial (DOID:13810)
- Prostate cancer (DOID:10283)
Disease
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Characterization of human apolipoprotein B100 oligosaccharides in LDL subfractions derived from normal and hyperlipidemic plasma: deficiency of alpha-N-acetylneuraminyllactosyl-ceramide in light and small dense LDL particles. (2001 - Garner B, Harvey DJ, Royle L, Frischmann M, Nigon F, Chapman MJ, Rudd PM) / Status : Reviewed
- O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. (2000 - Mattu T, Royle L, Langridge J, Wormald M, Van den Steen P, Van Damme J, Opdenakker G, Harvey D, Dwek R, Rudd P) / Status : Reviewed
- Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. (1995 - Dell A, Morris H, Easton R, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark G) / Status : Reviewed
- Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. (1995 - Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Structures of sugar chains of hen egg yolk riboflavin-binding protein. (1993 - Tarutani M, Norioka N, Mega T, Hase S, Ikenaka T) / Status : Reviewed
- Detailed structural analysis of asparagine-linked oligosaccharides of the nicotinic acetylcholine receptor from Torpedo californica. (1992 - Shoji H, Takahashi N, Nomoto H, Ishikawa M, Shimada I, Arata Y, Hayashi K) / Status : Reviewed
- Structures of acidic O-linked polylactosaminoglycans on human skim milk mucins. (1990 - Hanisch F, Peter-Katalinic J, Egge H, Dabrowski U, Uhlenbruck G) / Status : Reviewed
- Primary structure of twenty three neutral and monosialylated oligosaccharides O-glycosidically linked to the human secretory immunoglobulin A hinge region determined by a combination of permethylation analysis and 400-MHz 1H-NMR spectroscopy. (1989 - Pierce-Cretel A, Decottignies J, Wieruszeski J, Strecker G, Montreuil J, Spik G) / Status : Reviewed
- A carbohydrate structural variant of MM glycoprotein (glycophorin A). (1983 - Adamany A, Blumenfeld O, Sabo B, McCreary J) / Status : Reviewed
Reference
- ADAM DEC1 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Alpha-fetoprotein / Homo sapiens
- Alpha-mannosidase 2 / Homo sapiens
- Apolipoprotein b-100 / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Apolipoprotein M / Homo sapiens
- Asporin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Cadherin-2 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 / Homo sapiens
- Epididymis-specific alpha-mannosidase / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibronectin / Homo sapiens
- Glycodelin-a / Homo sapiens
-
Glycophorin-A / Homo sapiens
- Undefined site
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
-
Immunoglobulin alpha (secretory) / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-5 / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
-
Matrix metalloproteinase-9 / Homo sapiens
- Undefined site
- Myelin protein P0 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prominin-1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
- Prothrombin / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Reelin / Homo sapiens
- Reticulocalbin-3 / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
- Serotransferrin / Homo sapiens
- Serum paraoxonase/arylesterase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Tenascin-N / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
-
Uncharacterized protein from Serum / Homo sapiens
- Undefined site
- Uncharacterized protein KIAA0232 / Homo sapiens
-
Unspecified mucin / Homo sapiens
- Undefined site
- Von willebrand factor / Homo sapiens
- CD166 antigen / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Glutamate receptor 3 / Mus musculus
- Laminin subunit alpha-2 / Mus musculus
- Laminin subunit gamma-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
-
Riboflavin-binding protein / Gallus gallus
- Undefined site
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- YVNMSNHHR (9aa)
- HENNTKDNSIQHEFSLTR (18aa)
- WQMNFTVR (8aa)
- WFSAGLASNSSWLR (14aa)
- YETTNK (6aa)
- FSNVTWF (7aa)
- CIQANYSIMENGK (13aa)
- FHAIHVSGTNGTKRF (15aa)
- DSVINLSESVEDGPK (15aa)
- DLQSLEDILHQVENK (15aa)
- DLQSLEDILHQVENKT (16aa)
- AQMYPLQEIQNL (12aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- TFYWDFYTNR (10aa)
- SNIDPSNVDSIFYAAQASQAISGCEISISNETK (33aa)
- DTGEINVTSIIDR (13aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIKVCE (19aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- TELFSSSCPGGIMLNETGQGYQR (23aa)
- EHEGAIYPDNTTDFQR (16aa)
- NATYGHYAPGEEFHDVEDAETYKK (24aa)
- NATYGHYAPGEEFHDVEDAETYK (23aa)
- YPHKPEINSTTHPGADLQENFCR (23aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- VCQDCPLLAPLNDTR (15aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- VYKPSAGNNSLYR (13aa)
- VYSSANNCTFE (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- EHAVFTSNQEEQDPANHTCGVK (22aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSALR (13aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- VVLHPNYSQVDIGLIK (16aa)
- KDNTTVTR (8aa)
- HANWTLTPLK (10aa)
- VMHGGANITGFQIVNNENPMVQQFIQR (27aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- EALENMNSTLK (11aa)
- LNSSTIK (7aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
- ITDIENGSIANIPR (14aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- ALHALNVTWR (10aa)
- VQPFNVTQGK (10aa)
- NLSLNIHGK (9aa)
- GTAGNAIMDGASQIMGENR (19aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- SINTTNVMGTSLTVR (15aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- AIPQPQNVTSIIGCTH (16aa)
- IIISPEENVTLTCTAENQLER (21aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- LNNSSPNSSGGVK (13aa)
- VFGSQNITTVK (11aa)
- SCSLEGNPVACINLSFCLNASGK (23aa)
- SCVAVTSAQPQNMSRR (16aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NVSDIIPR (8aa)
- TCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPR (39aa)
- ANYSLQIYPDESHYFHSVALK (21aa)
- ELHHLQEQNVSNAFLDK (17aa)
- FGGFNFS (7aa)
- SLGNVNFTVSAEALESQELCGTEVPSVPEHGRK (33aa)
- IPCSQPPQIEHGTINSSR (18aa)
- VVNSTTGPGEHIR (13aa)
- VPAQEKNF (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- VNSSLHSQISR (11aa)
- LHNLTTGTPAR (11aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- VEAAQNLTLPGSLR (14aa)
- FNSSYLQGTNQITGR (15aa)
- NYYADNQTCDGELLFNMTK (19aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- MEACMLNGTVIGPGK (15aa)
- TAGFCGNPSFHLYWPNK (17aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1770.6228)
- Esophageal cancer (DOID:5041)
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- Alpha-2-macroglobulin / Homo sapiens
- Haptoglobin / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Prostate-specific antigen (psa-1) / Homo sapiens
-
- N-Linked / Complex (avg mass : 1770.6228)
- Electric Organ (UBERON_0006869)
-
Acetylcholine receptor protein / Torpedo californica
- Undefined site
-
- N-Linked / Complex (avg mass : 1770.6228)
- Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. (1995 - Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N) / Status : Reviewed
- Structures of sugar chains of hen egg yolk riboflavin-binding protein. (1993 - Tarutani M, Norioka N, Mega T, Hase S, Ikenaka T) / Status : Reviewed
- Characterization of E-PHA-reactive alpha-fetoprotein isoforms by two-dimensional lectin affinity electrophoresis. (1993 - Taketa K, Fujii Y, Taga H) / Status : Reviewed
- Alpha-fetoprotein / Homo sapiens
-
Uncharacterized protein from Serum / Homo sapiens
- Undefined site
-
Riboflavin-binding protein / Gallus gallus
- Undefined site
-
- N-Linked / Complex (avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- Alpha-fetoprotein / Homo sapiens
-
- N-Linked / Complex (avg mass : 1770.6228)
- Amniotic Fluid (UBERON_0000173)
- Glycodelin-a / Homo sapiens
-
- N-Linked / Complex (avg mass : 1770.6228)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1770.6228)
- Diabetes Mellitus, Non-insulin dependent (DOID:9352)
- Hypercholesterolemia, Familial (DOID:13810)
-
Apolipoprotein b-100 / Homo sapiens
- Undefined site
-
- N-Linked / Undefined core (avg mass : 1770.6228)
- HEK293 (CVCL_0045)
-
Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1770.6228)
- Milk (UBERON_0001913)
-
Immunoglobulin alpha (secretory) / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1770.6228)
-
Glycophorin-A / Homo sapiens
- Undefined site
-
- O-Linked / Core 2 (avg mass : 1770.6228)
- Neutrophil (CL_0000775)
-
Matrix metalloproteinase-9 / Homo sapiens
- Undefined site
-
- O-Linked / Undefined core (avg mass : 1770.6228)
- Milk (UBERON_0001913)
-
Unspecified mucin / Homo sapiens
- Undefined site
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Blood Serum (UBERON_0001977)
- Brain (UBERON_0000955)
- Mammary Gland (UBERON_0001911)
- Umbilical Vein (UBERON_0002066) Endothelial Cell of Umbilical Vein (CL_0002618)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Structure 231
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)[GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)[GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-?)Gal(b1-?)GlcNAc(b1-?)Man(a1-?)[GlcNAc(b1-?)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Undefined core / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc + " + Hex + 2x HexNAc + NeuAc "
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis (2019 - Nicholas M. Riley, Alexander S. Hebert, Michael S. Westphall & Joshua J. Coon ) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis (2014 - Liu M, Zhang Y, Chen Y, Yan G, Shen C, Cao J, Zhou X, Liu X, Zhang L, Shen H, Lu H, He F, Yang P) / Status : Reviewed
- Glycoproteomic analysis of the secretome of human endothelial cells (2013 - Yin X, Bern M, Xing Q, Ho J, Viner R, Mayr M.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- ADAM DEC1 / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-2-HS-glycoprotein / Homo sapiens
- Alpha-2-macroglobulin / Homo sapiens
- Alpha-mannosidase 2 / Homo sapiens
- Apolipoprotein b-100 / Homo sapiens
- Apolipoprotein d / Homo sapiens
- Apolipoprotein M / Homo sapiens
- Asporin / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Biglycan / Homo sapiens
- Cadherin-2 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Collagen alpha-1(XII) chain / Homo sapiens
- Complement factor h / Homo sapiens
- Corticosteroid-binding globulin / Homo sapiens
- Decorin / Homo sapiens
- Desmoglein-2 / Homo sapiens
- Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 / Homo sapiens
- Epididymis-specific alpha-mannosidase / Homo sapiens
- Fibrillin-1 / Homo sapiens
- Fibrinogen beta chain / Homo sapiens
- Fibrinogen gamma chain / Homo sapiens
- Fibronectin / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor receptor / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant gamma 1 / Homo sapiens
- Immunoglobulin heavy constant gamma 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Integrin alpha-5 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Myelin protein P0 / Homo sapiens
- Periostin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prominin-1 / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prothrombin / Homo sapiens
- Recombinant mature angiotensin-converting enzyme 2 / Homo sapiens
- Reelin / Homo sapiens
- Reticulocalbin-3 / Homo sapiens
- RNA polymerase II elongation factor ELL2 / Homo sapiens
- Serotransferrin / Homo sapiens
- Serum paraoxonase/arylesterase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Tenascin-N / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Transmembrane glycoprotein NMB / Homo sapiens
- Uncharacterized protein KIAA0232 / Homo sapiens
- Von willebrand factor / Homo sapiens
- CD166 antigen / Mus musculus
- Dipeptidyl aminopeptidase-like protein 6 / Mus musculus
- Glutamate receptor 3 / Mus musculus
- Laminin subunit alpha-2 / Mus musculus
- Laminin subunit gamma-1 / Mus musculus
- Neural cell adhesion molecule L1 / Mus musculus
- Thy-1 membrane glycoprotein / Mus musculus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- YVNMSNHHR (9aa)
- HENNTKDNSIQHEFSLTR (18aa)
- WQMNFTVR (8aa)
- WFSAGLASNSSWLR (14aa)
- YETTNK (6aa)
- FSNVTWF (7aa)
- CIQANYSIMENGK (13aa)
- FHAIHVSGTNGTKRF (15aa)
- DSVINLSESVEDGPK (15aa)
- DLQSLEDILHQVENK (15aa)
- DLQSLEDILHQVENKT (16aa)
- AQMYPLQEIQNL (12aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- TFYWDFYTNR (10aa)
- SNIDPSNVDSIFYAAQASQAISGCEISISNETK (33aa)
- DTGEINVTSIIDR (13aa)
- DGSIVIHNLDYSDNGTFTCDVK (22aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIKVCE (19aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- LSLHRPALEDLLLGSEANLTCTLTGLR (27aa)
- TELFSSSCPGGIMLNETGQGYQR (23aa)
- EHEGAIYPDNTTDFQR (16aa)
- NATYGHYAPGEEFHDVEDAETYKK (24aa)
- NATYGHYAPGEEFHDVEDAETYK (23aa)
- YPHKPEINSTTHPGADLQENFCR (23aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- VCQDCPLLAPLNDTR (15aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- CGLVPVLAENYNKSDNCEDTPEAGYFAVAVVK (32aa)
- VYKPSAGNNSLYR (13aa)
- VYSSANNCTFE (11aa)
- AALAAFNAQNNGSNFQLEEISR (22aa)
- EHAVFTSNQEEQDPANHTCGVK (22aa)
- MVSHHNLTTGATLINEQWLLTTAK (24aa)
- QIGLYPVLVIDSSGYVNPNYTGR (23aa)
- SWPAVGNCSSALR (13aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- IADTNITSIPQGIPPSITEIHIDGNK (26aa)
- VVLHPNYSQVDIGLIK (16aa)
- KDNTTVTR (8aa)
- HANWTLTPLK (10aa)
- VMHGGANITGFQIVNNENPMVQQFIQR (27aa)
- YIGNATAIFFIPDEGK (16aa)
- YLGNATAIFFLPDEGK (16aa)
- EALENMNSTLK (11aa)
- LNSSTIK (7aa)
- DLPIMFDVLIHDPSHFLNYSTINYK (25aa)
- ITDIENGSIANIPR (14aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- VIYQNHNK (8aa)
- IIQVVYIHSNNITK (14aa)
- ALHALNVTWR (10aa)
- VQPFNVTQGK (10aa)
- NLSLNIHGK (9aa)
- GTAGNAIMDGASQIMGENR (19aa)
- ENLTAPGSDSAVFFEQGTTR (20aa)
- SINTTNVMGTSLTVR (15aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- AIPQPQNVTSIIGCTH (16aa)
- IIISPEENVTLTCTAENQLER (21aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- LNNSSPNSSGGVK (13aa)
- VFGSQNITTVK (11aa)
- SCSLEGNPVACINLSFCLNASGK (23aa)
- SCVAVTSAQPQNMSRR (16aa)
- SCVAVTSAQPQNMSR (15aa)
- RHEEGHMINCTCFGQGR (17aa)
- EVNDTLLVNELK (12aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NVSDIIPR (8aa)
- TCSPWSHSEETRSDNETLNIQFEESTQFNAEDINYVVPR (39aa)
- ANYSLQIYPDESHYFHSVALK (21aa)
- ELHHLQEQNVSNAFLDK (17aa)
- FGGFNFS (7aa)
- SLGNVNFTVSAEALESQELCGTEVPSVPEHGRK (33aa)
- IPCSQPPQIEHGTINSSR (18aa)
- VVNSTTGPGEHIR (13aa)
- VPAQEKNF (8aa)
- EGVFVSNGTHWFVTQR (16aa)
- NGTHWFV (7aa)
- NGTHWFVT (8aa)
- VNSSLHSQISR (11aa)
- LHNLTTGTPAR (11aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
- VEAAQNLTLPGSLR (14aa)
- FNSSYLQGTNQITGR (15aa)
- NYYADNQTCDGELLFNMTK (19aa)
- NLQVYNATSNSLTVK (15aa)
- MIEAYNITEK (10aa)
- MEACMLNGTVIGPGK (15aa)
- TAGFCGNPSFHLYWPNK (17aa)
- FVEGSHNSTVSLTTK (15aa)
- YDFNSSMLYSTAK (13aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reported glycosite
Disease
Reported glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reference
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reference
Reported glycosite
